Angel News

Angel News

Back to Homepage

16th July 2018

Sight Diagnostics Launches OLO

OurCrowd backed Sight Diagnostics has launched OLO, an AI-based blood diagnostics device which offers lab-quality Complete Blood Count (CBC) tests from finger prick samples at the point-of-care. The company also announces the completion of a 250-person clinical trial at Israel’s Shaare Zedek Medical Center, which led to a CE Mark registration for OLO. This European regulatory certification indicates OLO’s conformity with high safety, health, and environmental protection standards and allows for commercial sale in countries that require CE marking.


Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:




Enter the characters in the image shown:

Back to Homepage